{"id":"https://genegraph.clinicalgenome.org/r/742f6079-b0e4-4365-99e4-f472381b18bcv1.0","type":"EvidenceStrengthAssertion","dc:description":"*LRP5 *was first reported in relation to autosomal dominant polycystic liver disease with or without kidney cysts in 2014 (Cnoseen et al., PMID: 24706814). Of note, *LRP5 *is associated with a number of gene-disease relationships in OMIM. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, given differences in phenotype and inheritance patterns, these different clinical entities were split. This curation focuses only on the association between *LRP5 *and autosomal dominant polycystic liver disease with or without kidney cysts. Four variants (all missense) that have been reported in *LRP5 *probands in one publication (PMID: 24706814) are included in this curation. Given this curation focuses on monoallelic disease, publications supporting the role of *LRP5 *in modifying phenotype in patients with an alternate genetic mechanism for their cystic disease were not included in this curation. This gene-disease association is also supported by expression studies that demonstrated *LRP5 *expression in liver tissue (PMID: 24706814) and studies that demonstrate that LRP5 has a role in the WNT-signaling pathway that is associated with polycystic liver disease (PMID: 30361437). In summary, there is limited evidence to support a gene-disease relationship between *LRP5 *and autosomal dominant polycystic liver disease with or without kidney cysts. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Cystic and Ciliopathy Disorders GCEP on 8/12/2020 (SOP Version 7). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/742f6079-b0e4-4365-99e4-f472381b18bc","GCISnapshot":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2020-08-12T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2022-02-22T14:03:57.233Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15670e4a-d1db-44f1-a60b-12a433dfd41e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/180d2a36-75f5-4056-b111-b9aae9ddec67","type":"FunctionalAlteration","dc:description":"Over-expression of mutatnt LRP5 constructs in CHO, H69 and HEK293 cells increased basal and Wnt3a-induced luciferase activity compared with empty vector","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"Luciferase assay"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35ce64a6-55c7-41b2-bca4-9e65418204f4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d50ae774-f053-4c34-abf3-d2aee84c2bc3","type":"Finding","dc:description":"PMID 11336703\nPMID: 27214281","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11336703","rdfs:label":"Cell Culture, Transfection and Luciferase Assay","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/213e3001-e0f0-45d6-971a-32bb1f5bd489","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce81e34a-4ba4-4467-a6e4-05058b5a5d5a","type":"Finding","dc:description":"IHC in control human liver tissue","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"Immunohistochemistry","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd8a97eb-a157-4826-b599-3ea91da25046","type":"EvidenceLine","dc:description":"Not associated with liver cysts","calculatedScore":0.1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd8a97eb-a157-4826-b599-3ea91da25046_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/fd8a97eb-a157-4826-b599-3ea91da25046_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920554","allele":{"id":"https://genegraph.clinicalgenome.org/r/a0ca6977-fe1d-47c0-b6a8-08e5e3211453","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002335.4(LRP5):c.3403C>T (p.Arg1135Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA210923"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ac6039e3-ae8a-4253-b2ee-44d48eb8b484","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac6039e3-ae8a-4253-b2ee-44d48eb8b484_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","allele":{"id":"https://genegraph.clinicalgenome.org/r/46731caa-8f99-4455-aafd-2e401802a1fc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002335.4(LRP5):c.4587G>C (p.Arg1529Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA210909"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bd687b19-a0bb-49d8-962c-4ff5bf581e77","type":"EvidenceLine","dc:description":"57yo male with no evidence of liver cysts and no family history","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd687b19-a0bb-49d8-962c-4ff5bf581e77_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase activity assays of variant LRP5 compared with WT LRP5\nconstructs were conducted to estimate Wnt signaling defects. Addition\nof ligand Wnt3a reduced Wnt signaling activity in LRP5 variants\np.(Trp560Cys), p.(Arg1036Gln) and p.(Gln1156His).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bd687b19-a0bb-49d8-962c-4ff5bf581e77_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920554","allele":{"id":"https://genegraph.clinicalgenome.org/r/89dcf343-947a-4b3c-96fb-61cc16844b32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002335.4(LRP5):c.3107G>A (p.Arg1036Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA210921"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/fd46a2a2-e678-48fc-8d79-8d6ec279bba7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd46a2a2-e678-48fc-8d79-8d6ec279bba7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase activity assays with LRP5WT, one extracellularly (R1188W) and one intracellularly located (D1551N) mutant, and an empty expression vector as a control. In the presence of Wnt3a, signal activation was significantly down-regulated by 30% and 45%, taking into account the basal activity in both LRP5 mutants compared with the LRP5WT. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fd46a2a2-e678-48fc-8d79-8d6ec279bba7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","allele":{"id":"https://genegraph.clinicalgenome.org/r/f823df14-8d7c-451b-a0be-389eba14550c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002335.4(LRP5):c.4651G>A (p.Asp1551Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA210911"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6225e6ab-2be5-4d54-9a7a-200b7c485a3f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6225e6ab-2be5-4d54-9a7a-200b7c485a3f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase activity assays with LRP5WT, one extracellularly (R1188W) and one intracellularly located (D1551N) mutant, and an empty expression vector as a control. In the presence of Wnt3a, signal activation was significantly down-regulated by 30% and 45%, taking into account the basal activity in both LRP5 mutants compared with the LRP5WT. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6225e6ab-2be5-4d54-9a7a-200b7c485a3f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","allele":{"id":"https://genegraph.clinicalgenome.org/r/cef37b7f-efc1-43b8-9705-65fb41653de1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002335.4(LRP5):c.3562C>T (p.Arg1188Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA210907"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/88598ee0-3fb5-4e83-bc4d-c097ba08c587","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88598ee0-3fb5-4e83-bc4d-c097ba08c587_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","allele":{"id":"https://genegraph.clinicalgenome.org/r/27087d1f-dd6d-418e-87df-8d84223a8082","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002335.4(LRP5):c.1360G>A (p.Val454Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA210927"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/dd2a14d4-0c98-4b0d-bee8-a0c5f3550009_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4566203b-d206-4d1f-9bf4-c780c3013dcb_proband_segregation","type":"FamilyCosegregation","dc:description":"2 segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD-3","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/4566203b-d206-4d1f-9bf4-c780c3013dcb","type":"Family","rdfs:label":"PCLD-3","member":{"id":"https://genegraph.clinicalgenome.org/r/98453793-2a24-438e-a7e3-e805fc47e5c1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD3 II/1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":43,"allele":{"id":"https://genegraph.clinicalgenome.org/r/46731caa-8f99-4455-aafd-2e401802a1fc"},"detectionMethod":"Method for LRP5 sequencing not specified","previousTesting":true,"previousTestingDescription":"PRKCSH, SEC63, PKD2 - analysis method not specified","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ac6039e3-ae8a-4253-b2ee-44d48eb8b484_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/98453793-2a24-438e-a7e3-e805fc47e5c1"}},{"id":"https://genegraph.clinicalgenome.org/r/6df0a7e4-cd46-4436-b0f1-91c6a167cfd6_proband_segregation","type":"FamilyCosegregation","dc:description":"The two original family members underwent exome sequencing\nThere are no coverage metrics published of coverage in linkage region","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD-1","family":{"id":"https://genegraph.clinicalgenome.org/r/6df0a7e4-cd46-4436-b0f1-91c6a167cfd6","type":"Family","rdfs:label":"PCLD-1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6b0724da-fc54-46c8-9ed9-d34ea01a8d26","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD1 III/18","allele":{"id":"https://genegraph.clinicalgenome.org/r/cef37b7f-efc1-43b8-9705-65fb41653de1"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6225e6ab-2be5-4d54-9a7a-200b7c485a3f_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":19,"proband":{"id":"https://genegraph.clinicalgenome.org/r/6b0724da-fc54-46c8-9ed9-d34ea01a8d26"},"publishedLodScore":4.62,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/dde70b9d-8777-4b21-8587-0ae188ed999e_proband_segregation","type":"FamilyCosegregation","dc:description":"only 1 segregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD-2","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/dde70b9d-8777-4b21-8587-0ae188ed999e","type":"Family","rdfs:label":"PCLD-2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9b23355b-5c96-4e32-b784-063d040c5f07","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD2 II/1","allele":{"id":"https://genegraph.clinicalgenome.org/r/27087d1f-dd6d-418e-87df-8d84223a8082"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/88598ee0-3fb5-4e83-bc4d-c097ba08c587_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/9b23355b-5c96-4e32-b784-063d040c5f07"}},{"id":"https://genegraph.clinicalgenome.org/r/b5921025-982c-465d-9328-c38355203d46_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD-4","family":{"id":"https://genegraph.clinicalgenome.org/r/b5921025-982c-465d-9328-c38355203d46","type":"Family","rdfs:label":"PCLD-4","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9d4d5ade-3e7a-4d85-963d-bfcab878ab65","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24706814","rdfs:label":"PCLD-4 II/3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":65,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f823df14-8d7c-451b-a0be-389eba14550c"},"detectionMethod":"Method for LRP5 sequencing not specified","ethnicity":{"id":"cg:NotHispanicOrLatino"},"previousTesting":true,"previousTestingDescription":"PRKCSH, SEC63, PKD2 - analysis method not specified","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fd46a2a2-e678-48fc-8d79-8d6ec279bba7_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/9d4d5ade-3e7a-4d85-963d-bfcab878ab65"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.2}],"evidenceStrength":"Limited","sequence":4013,"specifiedBy":"GeneValidityCriteria7","strengthScore":4.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/exeDLlSYvwE","type":"GeneValidityProposition","disease":"obo:MONDO_0044327","gene":"hgnc:6697","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_dd2a14d4-0c98-4b0d-bee8-a0c5f3550009-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}